|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���˿��� |
|
������������ |
|
�����֯�� |
| ��������������� | |
|
�������� |
|
��־ǿ��У |
| PubMed | |
|
Article by |
|
Article by |
���˿��������������������ٴ�Ӧ��
��������, ��־ǿ��У
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���
�����֯����һ������ٴ�֢״�ص������������Լ���,���˿�������������������ڽ����֯�����������Ҫ���á��־��ٴ��������ȷѡ������Ŀ,��ȷʹ��ʵ������ϼ�������ⲡ�̺��ж�Ԥ�����һ������
[2] Mutasim DF,Adams BB.A practical guide for serologic evaluation of autoimmune connective tissue diseases.J Am Acad Dematol,2000,42(2Ptl):159-174.
[3] Kavanaugh A,Tomar R,Reveille J,et al.Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens.Arch Pathol Lab Med,2000,124(1):71-81.
[4] Dore N,Synkowski D,Provost TT.Antinuclear antibody determinations in Ro (SS-A)-positive,antinuclear antibody-negative lupus and Sjogron's syndrome patients.J Am Acad Dermgtol,1983,8(5):611-4615.
[5] Suarez-Almazor ME,G,onzalez-Lopez L,Gamez-Nava JI,et al.Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.J Rheumatol,1998,25 (10):1980-1985.
[6] Takeuchi Y,Ishikawa O,Miyachi Y.The comparative study of anti-dou-ble stranded DNA antibody levels measured by radioimmunoassay and en-zyme-linked immnosorbent assay in systemic lupus erythematosus.J Dermatol,1997,24(5):297-300.
[7] Barada FA Jr,Andrews BS,Davis JS,et al.Antibodies to Sm in patients with SLE.Correlation of Sm antibody titers with disease activity and other laboratory parameters.Arthritis Rheum,1981,24(10):1236-1244.
[8] Sprionk PE,Limburg PC,Kallenberg GM.Serologic markers of disease activity in SLE.Lupus,1995,4:86-94.
[9] Thompson D,Juby A,Davis P.The clinical significance of autoantibody profiles in patients with SLE.Lupus,1993,2(1):15-19.
[10] Sanchez-Guerrero J,Lew RA,Fossel AH,et al.Utility of anti-Sm,anti-RNP,anti-Ro/SS-A and anti-La/SS-B (extractable nuclear antigens) detected by enzyme linked immunosorbent assay for the diagnosis of SLE.Arthritis Rheum,1996,39(6):1055-1061.
[11] Provost TT,Watson R,Simmons-O'Brien E.Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.J Am Acad Dermatol,1996,35(2Pt1):147-169.
[12] Yukiko N.Immunnoe responses to SS-A 52-kDa and 60-k Daproteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus.Br J Dermatol,2000,142(5):908-912.
[13] Jarzabek-Chorzelska M,Blaszczyk M,Jablonska S,et al.Scl-70 antibodies:a specific marker of systemic sclerosis.Br J Dermatol,1986,115 (4):393-401.
[14] Reveille JD,Durban E,Goldstein R,et al.Racial differences in the frequencies of scleroderma-related autoantibodies.Arthritis Rheum,1992,35(2):216-218.
[15] Combe B,Rucheton M,Graafiand H,et al.Clinical significance of anti-RNP and anti-Sm antoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue disease.Clin Exp Immunol,1989,75(1):18-24.
[16] Yoshida S,Akizuki M,Mimori T,et al.The precipitating antibody to an acitic nuclear protein antigen,the Jo-1,in connective tissue disease.A marker for a subset of polymyositis with interstitial pulmonary fibrosis.Arthritis Rheum,1983,26(5):604-611.
[17] Grossman L,Barland P.Histone reactivity of drug-induced antinuclear antibodies.A comparison of symptomatic and asymptomatic patients.Arthritis Rheum,1981,24(7):927-931.